Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(5 sites)
Australia
Gosford Hospital, Gosford, New South Wales Cancer Care Foundation, Miranda, New South Wales Wyong Hospital, Wyong, New South Wales Hong Kong
Queen Mary Hospital, Hong Kong Prince of Wales Hospital, Shatin